8I5G: Human Nav1.7

Structure of human Nav1.7 in complex with PF-05089771. Determined by electron microscopy at 2.7 Å resolution. Released 14 Jun 2023.

Method
Electron microscopy
Resolution
2.7 Å
Organism
Homo sapiens
Chains
3
Atoms
13,389
Mol. weight
285.4 kDa
Ligands
Y01, 9Z9, LPE, PCW
Released
14 Jun 2023

Explore 8I5G in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

8I5G contains 80 α-helices and 43 β-strands across 3 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 74 helices, 18 β-strands

ElementResiduesLengthSheet
β-strand1418
α-helix17-3317
β-strand5819
α-helix59-602
α-helix61-633
α-helix65-673
β-strand7518
β-strand87-9158
β-strand9619
β-strand97-10158
β-strand105110
β-strand109110
α-helix114-12310
α-helix126-14318
α-helix152-17423
α-helix187-20519
α-helix210-2167
α-helix217-2248
α-helix231-24313
α-helix246-26722
α-helix270-2723
β-strand273-277511
α-helix286-2905
α-helix296-2994
β-strand303111
α-helix312-3143
α-helix324-3252
β-strand328-332511
α-helix335-3362
α-helix338-3403
α-helix347-35913
α-helix363-37412
α-helix376-3783
α-helix379-3857
α-helix386-3938
α-helix394-41724
α-helix729-74012
α-helix743-7475
α-helix748-76013
α-helix761-7633
α-helix770-79728
α-helix800-8034
α-helix807-82418
α-helix834-84714
α-helix850-86314
α-helix867-89428
α-helix896-8983
α-helix913-92513
α-helix929-93911
α-helix941-96828
α-helix969-9735
α-helix987-101327
α-helix1176-118914
α-helix1192-120716
α-helix1208-12114
α-helix1216-12183
α-helix1220-125536
α-helix1257-127721
α-helix1284-12907
α-helix1291-12999
α-helix1300-13034
α-helix1305-134339
β-strand1349-1352412
β-strand1357-1358212
α-helix1359-13602
β-strand1366113
α-helix1367-137610
β-strand1380-1383412
α-helix1392-140413
α-helix1408-14169
β-strand1423113
α-helix1431-14333
α-helix1434-14418
α-helix1442-14476
α-helix1448-146619
α-helix1476-148813
α-helix1491-150010
α-helix1503-151311
α-helix1515-153420
α-helix1541-156929
α-helix1570-15756
α-helix1577-160226
α-helix1606-16127
α-helix1613-16164
α-helix1617-16204
α-helix1621-16255
α-helix1628-166538
α-helix1684-169512
α-helix1700-17078
β-strand1720114
β-strand1727114
α-helix1733-176634
Chain B: 4 helices, 12 β-strands
ElementResiduesLengthSheet
α-helix25-273
β-strand29-3131
β-strand36-3832
β-strand4113
β-strand50-61124
β-strand68-7474
β-strand77-8044
β-strand90-9232
β-strand10313
β-strand106-10832
α-helix113-1153
β-strand117-129134
β-strand132-144134
β-strand145-14731
α-helix151-1533
α-helix154-19138
Chain C: 2 helices, 13 β-strands
ElementResiduesLengthSheet
β-strand31-3335
β-strand37-4156
β-strand46-4837
β-strand51-5335
β-strand64-7076
β-strand78-8366
β-strand87-8936
β-strand99-10137
β-strand10415
α-helix105-1073
β-strand10915
β-strand112-11437
α-helix119-1213
β-strand123-13086
β-strand138-147106

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Sodium channel subunit beta-1Bprotein192Homo sapiensQ07699 (AlphaFold model)
Sodium channel subunit beta-2Cprotein215Homo sapiensO60939 (AlphaFold model)
Sodium channel protein type 9 subunit alphaAprotein1988Homo sapiensQ15858 (AlphaFold model)
Sequence of entity 1 (B), FASTA
>8I5G_1 Sodium channel subunit beta-1 (chains B)
MGRLLALVVGAALVSSACGGCVEVDSETEAVYGMTFKILCISCKRRSETNAETFTEWTFR
QKGTEEFVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIFITNVTYNHSGDYE
CHVYRLLFFENYEHNTSVVKKIHIEVVDKANRDMASIVSEIMMYVLIVVLTIWLVAEMIY
CYKKIAAATETA
Sequence of entity 2 (C), FASTA
>8I5G_2 Sodium channel subunit beta-2 (chains C)
MHRDAWLPRPAFSLTGLSLFFSLVPPGRSMEVTVPATLNVLNGSDARLPCTFNSCYTVNH
KQFSLNWTYQECNNCSEEMFLQFRMKIINLKLERFQDRVEFSGNPSKYDVSVMLRNVQPE
DEGIYNCYIMNPPDRHRGHGKIHLQVLMEEPPERDSTVAVIVGASVGGFLAVVILVLMVV
KCVRRKKEQKLSTDDLKTEEEGKTDGEGNPDDGAK
Sequence of entity 3 (A), FASTA
>8I5G_3 Sodium channel protein type 9 subunit alpha (chains A)
MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLP
FIYGDIPPGMVSEPLEDLDPYYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISI
KILVHSLFSMLIMCTILTNCIFMTMNNPPDWTKNVEYTFTGIYTFESLVKILARGFCVGE
FTFLRDPWNWLDFVVIVFAYLTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQ
SVKKLSDVMILTVFCLSVFALIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFR
KYFYYLEGSKDALLCGFSTDSGQCPEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQ
DYWENLYQQTLRAAGKTYMIFFVVVIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKE
LEFQQMLDRLKKEQEEAEAIAAAAAEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRR
KKKNQKKLSSGEEKGDAEKLSKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIR
GSLFSARRSSRTSLFSFKGRGRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSS
NISQASRSPPMLPVNGKMHSAVDCNGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGT
TNQIHKKRRCSSYLLSEDMLNDPNLRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHK
FLIWNCSPYWIKFKKCIYFIVMDPFVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGN
LVFTGIFAAEMVLKLIAMDPYEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLL
RVFKLAKSWPTLNMLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKIN
DDCTLPRWHMNDFFHSFLIVFRVLCGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVL
NLFLALLLSSFSSDNLTAIEEDPDANNLQIAVTRIKKGINYVKQTLREFILKAFSKKPKI
SREIRQAEDLNTKKENYISNHTLAEMSKGHNFLKEKDKISGFGSSVDKHLMEDSDGQSFI
HNPSLTVTVPIAPGESDLENMNAEELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEE
AEAEPMNSDEPEACFTDGCVWRFSCCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVL
MILLSSGALAFEDIYIERKKTIKIILEYADKIFTYIFILEMLLKWIAYGYKTYFTNAWCW
LDFLIVDVSLVTLVANTLGYSDLGPIKSLRTLRALRPLRALSRFEGMRVVVNALIGAIPS
IMNVLLVCLIFWLIFSIMGVNLFAGKFYECINTTDGSRFPASQVPNRSECFALMNVSQNV
RWKNLKVNFDNVGLGYLSLLQVATFKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVF
IIFGSFFTLNLFIGVIIDNFNQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRP
GNKIQGCIFDLVTNQAFDISIMVLICLNMVTMMVEKEGQSQHMTEVLYWINVVFIILFTG
ECVLKLISLRHYYFTVGWNIFDFVVVIISIVGMFLADLIETYFVSPTLFRVIRLARIGRI
LRLVKGAKGIRTLLFALMMSLPALFNIGLLLFLVMFIYAIFGMSNFAYVKKEDGINDMFN
FETFGNSMICLFQITTSAGWDGLLAPILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYF
VSYIIISFLVVVNMYIAVILENFSVATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFS
KLSDFAAALDPPLLIAKPNKVQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDSLR
SQMEERFMSANPSKVSYEPITTTLKRKQEDVSATVIQRAYRRYRLRQNVKNISSIYIKDG
DRDDDLLNKKDMAFDNVNENSSPEKTDATSSTTSPPSYDSVTKPDKEKYEQDRTEKEDKG
KDSKESKK

Ligands and cofactors

IDNameFormulaCopies
Y01Cholesterol hemisuccinateC31 H50 O42
9Z9(3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-enC34 H56 O51
LPE1-O-octadecyl-sn-glycero-3-phosphocholineC26 H57 N O6 P8
PCW1,2-dioleoyl-sn-glycero-3-phosphocholineC44 H85 N O8 P5
T70PF-05089771C18 H12 Cl2 F N5 O3 S21
NAG2-acetamido-2-deoxy-beta-D-glucopyranoseC8 H15 N O65

Water and common crystallization additives (NA) are not listed.

Primary citation

Structural mapping of Na v 1.7 antagonists. Wu, Q., Huang, J., Fan, X. et al. Nat Commun (2023) 14:3224-3224. DOI 10.1038/s41467-023-38942-3 · PubMed

Other PDB entries of the same protein (UniProt Q07699 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 8I5G directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.